24 days ago
IBRX
AnalystsAndres Y. MaldonadoAndres Y. Maldonado's Stock Forecasts
AnalystsAndres Y. Maldonado
Sectors:
Industries:
Analyst Ranking
Top 5%
#263 out of 5220 analysts
Average Return
+52.29%
Win Rate
57%27 out of 47
Risk vs Reward
Poor
Good
Andres Y. Maldonado's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunitybio IncIBRX | +262.71% | $2.36 | $8.56 | 2025-05-12 - 2026-03-18 | Buy |
Immunitybio IncIBRX | +245.16% | $2.48 | $8.56 | 2025-04-16 - 2026-03-18 | Buy |
Immunitybio IncIBRX | +233.07% | $2.57 | $8.56 | 2025-09-10 - 2026-03-18 | Buy |
Immunitybio IncIBRX | +225.48% | $2.63 | $8.56 | 2025-04-28 - 2026-03-18 | Buy |
Immunitybio IncIBRX | +199.67% | $2.99 | $8.96 | 2025-03-06 - 2026-03-05 | Buy |
Andres Y. Maldonado Analyst Color
Get additional color on Andres Y. Maldonado's coverage of popular stocks
Andres Y. Maldonado's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novabridge BiosciencesNBP | 3 | Buy | $9.00 | +219.15% | Reiterates | 3 days ago |
Erasca IncERAS | 3 | Buy | $20.00 | +48.15% | Maintains | 6 days ago |
Foghorn Therapeutics IncFHTX | 1 | Buy | $13.00 | +166.39% | Reiterates | 9 days ago |
Day One Biopharmaceuticals IncDAWN | 3 | Hold | $21.50 | +0.89% | Downgrades | 9 days ago |
Engene Holdings IncENGN | 3 | Buy | $25.00 | +248.19% | Reiterates | 10 days ago |
Scholar Rock Holding CorpSRRK | 3 | Buy | $58.00 | +45.77% | Reiterates | 16 days ago |
Cg Oncology IncCGON | 5 | Buy | $80.00 | +24.13% | Maintains | 20 days ago |
Immunitybio IncIBRX | 9 | Buy | $15.00 | +75.23% | Maintains | 24 days ago |
Immunome IncIMNM | 1 | Buy | $40.00 | +93.99% | Initiates Coverage On | a month ago |
Protara Therapeutics IncTARA | 3 | Buy | $23.00 | +336.43% | Reiterates | a month ago |
Verastem IncVSTM | 1 | Buy | $18.00 | +223.74% | Assumes | a month ago |
Sutro Biopharma IncSTRO | 1 | Hold | $10.00 | -54.10% | Maintains | 3 months ago |
Werewolf Therapeutics IncHOWL | 1 | Buy | $4.00 | +374.50% | Maintains | 3 months ago |
Terns Pharmaceuticals IncTERN | 2 | Buy | $60.00 | +25.58% | Maintains | 3 months ago |
Tscan Therapeutics IncTCRX | 1 | Buy | $7.00 | +554.21% | Maintains | 4 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Buy | $40.00 | +69.13% | Reiterates | 5 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Buy | $40.00 | +341.99% | Reiterates | 5 months ago |
Merus NvMRUS | 1 | Hold | $97.00 | +7.78% | Downgrades | 6 months ago |
Candel Therapeutics IncCADL | 1 | Buy | $23.00 | +356.35% | Reiterates | 6 months ago |
Monopar TherapeuticsMNPR | 2 | Buy | $105.00 | +80.10% | Maintains | 6 months ago |
Aura Biosciences IncAURA | 1 | Buy | $22.00 | +234.35% | Reiterates | 7 months ago |
Keros Therapeutics IncKROS | 1 | Buy | $20.00 | +82.65% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.